Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Proteasome Inhibitors in Waldenström Macroglobulinemia — Efstathios Kastritis (2018) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Proteasome Inhibitors in Waldenström Macroglobulinemia
Shared by
Meletios A Dimopoulos
Proteasome Inhibitors in Waldenström Macroglobulinemia
Article
2018
en
Authors
EK
Efstathios Kastritis
Meletios A Dimopoulos
Related publications
Chapter in a book
2016
Immunomodulatory Agents and Proteasome Inhibitors in Waldenstrom’s Macroglobulinemia
Steven P. Treon
,
Jorge J. Castillo
,
Efstathios Kastritis
,
Meletios A Dimopoulos
Article
2013
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia
Meletios A Dimopoulos
,
Evangelos Terpos
,
Efstathios Kastritis
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
2023
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia
Eirini Solia
,
Meletios A Dimopoulos
,
Efstathios Kastritis
Article
2022
Managing Waldenström’s macroglobulinemia with BTK inhibitors
Christian Buske
,
Wojciech Jurczak
,
Joe‐Elie Salem
,
Meletios A Dimopoulos
Article
2021
Current and novel BTK inhibitors in Waldenström’s macroglobulinemia
Ioannis Ntanasis‐Stathopoulos
,
Maria Gavriatopoulou
,
Despina Fotiou
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.